A Swiss-Based Platform for
International Expansion, Capital Formation and Strategic Partnerships
A Swiss-Based Platform for
International Expansion, Capital Formation and Strategic Partnerships
Asia is becoming one of the world's most important sources of biotechnology innovation. From China, Taiwan, and South Korea to Singapore, Japan, and emerging biotech ecosystems across the region, scientific breakthroughs are increasingly shaping the future of global healthcare.
Trust Bridge Health™ is a Swiss-based growth platform that partners with visionary founders, innovative biotechnology companies, and investors to transform scientific innovation into globally recognized healthcare businesses.
Through capital formation, strategic partnerships, and international expansion, we seek to maximize long-term asset and enterprise value while improving patient outcomes.
To be the preferred growth and value creation partner for innovative Asian biotechnology companies seeking to maximize the global potential of their assets and enterprises.
Transforming Asia's scientific innovation into globally recognized biotechnology leaders.
Asia has evolved from a manufacturing base into a global source of scientific innovation.
Switzerland combines science, capital, manufacturing excellence, and global market access within one of the world's leading life sciences ecosystems.
• Home to major global pharmaceutical companies
• Access to international investors
• Strong intellectual property protection
• World-class regulatory expertise
• European market access
• International credibility and trust
Switzerland serves as a trusted bridge between innovation, capital, and commercialization, enabling Asian biotechnology companies to build enterprise value before major licensing, acquisition, or IPO events.
Trust Bridge Health™ is led by Antonio Carvalho, Managing Partner, who brings more than 25 years of international healthcare experience across pharmaceuticals, life sciences, and consumer healthcare. His career has included senior leadership roles, including Vice President and General Manager positions, at global organizations such as Novartis, Nycomed-Takeda, and DSM-Firmenich, with responsibilities spanning business development, licensing, M&A, commercial operations, and international expansion. Experience in healthcare investing, growth capital, and strategic transactions further complements this operational and industry background. Antonio is also an alumnus of Harvard Business School and Cardiff Business School.
The Swiss-based platform is supported by a lean, cross-functional network of professionals, advisors, and industry experts with experience spanning biotechnology, pharmaceuticals, clinical development, regulatory affairs, manufacturing, commercialization, healthcare investing, and strategic transactions.
Leveraging a Swiss-Asian network of pharmaceutical companies, investors, CROs, CDMOs, Key Opinion Leaders (KOLs), academic institutions, industry associations, and strategic partners, Trust Bridge Health brings together the expertise, relationships, and execution capabilities required to accelerate international growth, advance strategic partnerships, and maximize long-term asset and enterprise value.
Our approach is built on:
• Long-term alignment
• Shared value creation
• Flexible participation
• Founder-centric decision making
• International growth and value maximization
We seek long-term partnerships built on aligned interests, shared value creation, and a common ambition to build globally competitive healthcare businesses.
Our objective is to create long-term value for founders, investors, strategic partners, and ultimately the patients for whom these innovations are researched, developed, and commercialized.
